AFM
GRNA

Anson Funds Management’s GreenLight Biosciences Holdings, PBC Common Stock GRNA Stock Holding History

Anson Funds Management’s Portfolio GRNA Stock Details GRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-125,000
Closed -$1.24M – 407
2021
Q3 		$1.24M Hold
125,000
– – 0.12% 178
2021
Q2 		$1.23M Hold
125,000
– – 0.12% 175
2021
Q1 		$1.21M Buy
+125,000
New +$1.23M 0.14% 163

Other funds holding GRNA

HCM
Highbridge Capital Management New York $3.09B AUM 31.19% 1-Year Est. Return
FTCM
Fir Tree Capital Management New York $21.8M AUM 1.61% 1-Year Est. Return
Hudson Bay Capital Management
Hudson Bay Capital Management Stamford, Connecticut $29B AUM 30.2% 1-Year Est. Return
KC
Kryger Capital London, United Kingdom $1.41B AUM 86.31% 1-Year Est. Return
WAM
Weiss Asset Management Boston, Massachusetts $5.91B AUM 42.42% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return
AC
Aristeia Capital Greenwich, Connecticut $4.82B AUM 24.94% 1-Year Est. Return
CH
CVI Holdings Wilmington, Delaware $116M AUM 5.68% 1-Year Est. Return
KC
Kepos Capital New York $61.3M AUM 12.13% 1-Year Est. Return

Anson Funds Management's GRNA Position: Q4 2021 in Review

Anson Funds Management sold out of GreenLight Biosciences Holdings, PBC Common Stock (GRNA) in Q4 2021, closing a stake of 125,000 shares — an estimated $1.24M sold.

Anson Funds Management first reported a position in GRNA in Q1 2021 and held it in 3 quarters. The position peaked at $1.24M in Q3 2021. 68 funds tracked by Wall St. Rank hold GRNA as of Q4 2021.

  • Anson Funds Management reported no remaining GreenLight Biosciences Holdings, PBC Common Stock position as of Q4 2021 after selling out during the quarter.
  • Anson Funds Management sold 125,000 GreenLight Biosciences Holdings, PBC Common Stock shares in Q4 2021, an estimated $1.24M.
  • Anson Funds Management first reported a position in GreenLight Biosciences Holdings, PBC Common Stock in Q1 2021 and held it in 3 quarters.
  • Anson Funds Management's GreenLight Biosciences Holdings, PBC Common Stock position peaked at $1.24M in Q3 2021.
  • 68 funds tracked by Wall St. Rank held GreenLight Biosciences Holdings, PBC Common Stock as of Q4 2021.

Based on Anson Funds Management's 13F filing for Q4 2021, filed 14 Feb 2022.